FDA Approves Vosevi (sofosbuvir, velpatasvir and voxilaprevir) for Hepatitis C

Article Link: FDA Approves Vosevi (sofosbuvir, velpatasvir and voxilaprevir) for Hepatitis C



Source: FDA New Drug Approvals